Search PDMR transactions

Notifier
Name of person with notification obligation
Bent Frandsen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Bent Frandsen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
ExpreS2ion Biotech Holding AB
Issuer´s LEI code
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Warrant ExpreS2ion Biotech Holding TO 11 SE0022088118 Exercise decrease 196,800 Quantity 14.65 SEK 02/10/2025 Outside a trading venue
Share ExpreS2ion Biotech Holding AB SE0023261292 Exercise increase 4,920 Quantity 14.65 SEK 02/10/2025 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
ExpreS2ion Biotech Holding TO 11 SE0022088118 Exercise decrease 02/10/2025 Outside a trading venue 196,800 (Quantity) 14.65 SEK
ExpreS2ion Biotech Holding AB SE0023261292 Exercise increase 02/10/2025 Outside a trading venue 4,920 (Quantity) 14.65 SEK
<< Back